Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2025 09:12 ET | Source: Albatroz Therapeutics

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression

Nature study uncovers insights about the progression of osteoarthritis (OA) and rheumatoid arthritis; demonstrates therapeutic approach targeting Calnexin.
December 12, 2024 09:00 ET | Source: Exagen Inc.

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...
November 14, 2024 16:30 ET | Source: Exagen Inc.

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus...
July 26, 2023 07:30 ET | Source: Incannex Healthcare

Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis

MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
September 28, 2021 13:30 ET | Source: ALLIANCE DEVELOPPEMENT CAPITAL (ADC SIIC)

ALLIANCE DEVELOPPEMENT CAPITAL (ADC SIIC) : Communiqué sur la mise à disposition du rapport financier semestriel au 30.06.2021

ADC SIIC Société Européenne au capital de 20 572 093,32 euros Siège social : Avenue de l'Astronomie, 9 - Saint-Josse-ten-Noode - 1210 Bruxelles (Belgique) 0526.937.652 ...
August 23, 2021 15:52 ET | Source: Sorrento Therapeutics, Inc.

Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel

Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people in the United States (NIH, 2017).Sofusa is a revolutionary technology which delivers biologic...
July 29, 2020 09:00 ET | Source: SetPoint Medical

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis

VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS)...
November 12, 2019 09:00 ET | Source: eWellness Healthcare Corp

eWellness Announces the Developing New Rheumatoid Arthritis Treatment Platform RA360

Culver City, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth...
April 23, 2015 12:00 ET | Source: Principled Technologies

Deployment guide: Deploying a cloud on the NEC DX1000

DURHAM, NC--(Marketwired - April 23, 2015) - Principled Technologies developed a complete, free deployment guide that will show you how to easily prepare for, deploy, provision to, and scale a dense...